Investigating the Prevalence of PK Island in Enterobacteriacea
DOI:
https://doi.org/10.46966/msjar.v6i4.324Keywords:
Enterobacteriacea, Colibactin, PK islandAbstract
The Enterobacteriaceae family has a pathogenicity island that leads to increase in pathogenicity. Colibactin is a genotoxin that induces DNA double-strand breaks that may lead to carcinogenesis and is produced by Escherichia coli strains harboring the pks island. During study the detection of colibactin occurs by molecular method (polymerase chain reaction) followed by bacterial identification and DNA extraction. The result of study shows the bacterial E.coil is the most bacterial isolate found in enterobacteriacea sample used in study followed by Klebsiella contain the four genes that expressing of colibactin including (ClbA, ClbB, ClbQ and ClbN) representing the PK island.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Noor Ismeal lNasser, Fatima Hamza Alzubaidy, Taif Al-Saadi, Qassim M. Hashym
This work is licensed under a Creative Commons Attribution 4.0 International License.
In submitting the manuscript to the Medical Science Journal for Advance Research, the authors certify that:
- They are authorized by their co-authors to enter into these arrangements.
- The work described has not been formally published before, except in the form of an abstract or as part of a published lecture, review, thesis, or overlay journal.
- That it is not under consideration for publication elsewhere,
- The publication has been approved by the author(s) and by responsible authorities – tacitly or explicitly – of the institutes where the work has been carried out.
- They secure the right to reproduce any material that has already been published or copyrighted elsewhere.
- They agree to the following license and copyright agreement.
License and Copyright Agreement
Authors who publish with Medical Science Journal for Advance Research agree to the following terms:
- Authors retain copyright and grant the Medical Science Journal for Advance Research right of first publication with the work simultaneously licensed under Creative Commons Attribution License (CC BY 4.0) that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors can enter into separate, additional contractual arrangements for the non-exclusive distribution of the Medical Science Journal for Advance Research published version of the work (e.g., post it to an institutional repository or edit it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) before and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
